Tina Mumford, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3767 Garner Rd, Timmonsville, SC 29161 Phone: 803-673-8465 |
Melinda Gail Byrd, R.N. Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 304 Kemper St, Timmonsville, SC 29161 Phone: 843-346-3956 Fax: 843-346-5159 |
Vanity Mccray Timmons, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 304 Kemper St, Timmonsville, SC 29161 Phone: 843-346-3956 Fax: 843-346-5159 |
Jessica White, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 304 Kemper St, Timmonsville, SC 29161 Phone: 843-346-3956 Fax: 843-346-5159 |
Clarice Regina Mace, Registered Nurse - Community Health Medicare: Not Enrolled in Medicare Practice Location: 3316 Ellerbe Dr, Timmonsville, SC 29161 Phone: 843-618-0486 |
Sandy Stone, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3707 S Hill Rd, Timmonsville, SC 29161 Phone: 843-687-4701 |
News Archive
The American Journal of Gastroenterology published today a new study that reveals digestive symptoms, including diarrhea, are common in COVID-19 patients. The study comes from the Wuhan Medical Treatment Expert Group for COVID-19 in China.
The latest Harris Poll, measuring how many people use the Internet to look for information about health topics, finds that the numbers continue to increase. The Harris Poll first used the word Cyberchondriacs to describe these people in 1998, when just over 50 million American adults had ever gone online to look for health information. By 2005, that number had risen to 117 million. In the new poll, the number of Cyberchondriacs has jumped to 175 million from 154 million last year, possibly as a result of the health care reform debate.
Breast cancer stem cells wear a cell surface protein that is part nametag and part bull's eye, identifying them as potent tumor-generating cells and flagging their vulnerability to a drug, researchers at The University of Texas MD Anderson Cancer Center report online in Journal of Clinical Investigation.
Adamas Pharmaceuticals, Inc., a privately held company, announced today results from in vivo animal studies and in vitro tests demonstrating that its triple combination antiviral drug (TCAD) therapy is superior relative to double combinations and monotherapy against multiple strains of pandemic and avian influenza viruses. Results of these studies were presented Sunday evening in an oral session at the XII International Symposium on Respiratory Viral Infections being held in Taipei.
› Verified 6 days ago